Homocysteine status and cardiovascular risk factors in patients with psoriasis: A case-control study

Clinical and Experimental Dermatology

Volumn 36, Issue 1, 2011, Pages 19-23

  Tobin, A M ^a   Hughes, R ^a   Hand, E B ^b   Leong, T ^a   Graham, I M ^a   Kirby, B ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FOLIC ACID; GLUCOSE; HOMOCYSTEINE; RED CELL FOLATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FAMILY HISTORY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; PSORIASIS; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VITAMIN B 12;

EID: 78650111602     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2010.03877.x     Document Type: Article

References (24)

1. Pearce DJ, Morrison AE, Higgins KB et al. The comorbid state of psoriasis patients in a university dermatology practice. J Dermatolog Treat 2005; 16: 319-23.
2. McDonald CJ, Calabresi P. Thromboembolic disorders associated with psoriasis. Arch Dermatol 1973; 107: 918.
3. Mallbris L, Akre O, Granath F et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004; 19: 225-30.
4. Poikolainen K, Karvonen J, Pukkala E. Excess mortality related to alcohol and smoking among hospital treated patients with psoriasis. Arch Dermatol 1999; 135: 1490-3.
5. Lindegard B. Diseases associated with psoriasis in a general population of 159, 200 middle-aged urban, native Swedes. Dermatologica 1986; 172: 298-304.
6. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982-6.
7. Gelfand JM, Neiman AL, Shin DB et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-41.
8. Ludwig RJ, Herzog C, Rostock A et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007; 156: 271-6.
9. Kremers HM, McEvoy MT, Dann FJ, Gabriel SE. Heart disease in psoriasis. J Am Acad Dermatol 2007; 57: 347-54.
10. Graham IM, Daly LE, Refsum HM et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 277: 1775-81.
11. Mayer O, Filipovsky J, Dolejsova M et al. Mild hyperhomocysteinaemia is associated with increased aortic stiffness in general population. J Hum Hypertens 2006; 20: 267-71.
12. Malerba M, Gisondi P, Radaeli A et al. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. Br J Dermatol 2006; 155: 1165-9.
13. Vanizor Kural B, Orem A, Cimsit G et al. Plasma homocysteine and its relationship with atherothrombotic markers in psoriatic patients. Clin Chim Acta 2003; 332: 23-30.
14. Refsum H, Helland S, Ueland PM. Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patients receiving low-dose methotrexate treatment. Clin Pharmacol Ther 1989; 46: 510-20.
15. Hild DH. Folate losses from the skin in exfoliative dermatitis. Arch Intern Med 1969; 123: 51-7.
16. Fry L, Macdonald A, Almeyda J et al. The mechanism of folate deficiency in psoriasis. Br J Dermatol 1971; 84: 539-44.
17. Touraine R, Revuz J, Zittoun J et al. Study of folate in psoriasis: blood levels, intestinal absorption and cutaneous loss. Br J Dermatol 1973; 89: 335-41.
18. Daly L, Kirke P, Molloy A et al. Folate levels and neural tube defects. Implications for prevention. JAMA 1995; 274: 1698-702.
19. Kimmons JE, Blanck HM, Tohill BC et al. Associations between body mass index and the prevalence of low micronutrient levels among US adults. MedGenMed 2006; 8: 59.
20. Sommer DM, Jenisch S, Suchan M et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006; 298: 32-8.
21. Gisondi P, Tesari G, Conti A et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007; 157: 68-73.
22. Cohen AD, Sherf M, Vidavsky L et al. Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology 2008; 216: 152-5.
23. Burke GL, Bertoni AG, Shea S et al. The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med 2008; 168: 928-35.
24. Lloyd-Jones DM, Leip EP, Larson MG et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006; 113: 791-8.